Clinical Trial Update: Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating differences in atorvastatin metabolite ratios as a diagnostic tool to detect atorvastatin-induced myotoxicity; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Statin-induced Myopathy

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: University of Oslo School of Pharmacy | Conditions: Myotoxicity of Atorvastatin Treatment | Phase 4 | Status: COMPLETED